Novartis Shuts Down San Diego Facility Owned by Alexandria Amidst Broad Restructuring

Pharmaceutical giant Novartis is set to shutter its San Diego facility as part of a larger restructuring initiative aimed at overhauling the company’s drug development segment. This move underscores the ongoing shifts within the pharmaceutical industry as companies seek to streamline operations and leverage global talent pools. In a recent notification to the state, Novartis […]